GlassScriptPhysician profile
James S Logan
NPI 1740260140
$5,659.37
in general payments reported to CMS, 2019-2025
38 companies · $436 in 2025
The $436 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,250 · 2020: $852 · 2021: $1,115 · 2022: $854 · 2023: $755 · 2024: $398 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,533 · Education: $39.84 · Entertainment: $16.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,532.88 |
| Education | $39.84 |
| Entertainment | $16.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,142.82 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $555.06 | 2019-2025 | Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $528.28 | 2021-2025 | |
| Abbvie INC. | $439.80 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $411.72 | 2019-2025 | |
| Kowa Pharmaceuticals America, INC. | $324.15 | 2019-2024 | Zoryve |
| Astrazeneca Pharmaceuticals LP | $273.49 | 2019-2025 | Farxiga, Breztri |
| Allergan, INC. | $224.45 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $199.93 | 2019-2022 | |
| Pfizer INC. | $185.59 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $168.73 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $160.58 | 2019-2024 | Xifaxan |
| Merck Sharp & Dohme LLC | $156.03 | 2019-2025 | Verquvo, Steglatro, Belsomra |
| Amarin Pharma, INC. | $121.16 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $76.74 | 2020-2023 | Austedo |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Logan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.